General MedicationsORALGeneric
NIZORAL
KETOCONAZOLE
Standard Dose
100MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NIZORAL is listed in Drugs@FDA under application 070767 (ANDA).
Marketing status: Discontinued Active ingredient KETOCONAZOLE Form and strength SUSPENSION;ORAL - 100MG/5ML Sponsor JANSSEN PHARMA Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NIZORAL is listed in Drugs@FDA under application 070767 (ANDA). Marketing status: Discontinued Active ingredient KETOCONAZOLE Form and strength SUSPENSION;ORAL - 100MG/5ML Sponsor JANSSEN PHARMA Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.